Nothing ruins a trip to Mexico like a case of Montezuma’s Revenge. A jaunt through India can stop dead in its tracks due to a bout of Delhi Belly. In other parts of the globe, the affliction is simply called “Traveler’s Diarrhea,” and there are estimates that it affects up to 40 percent of travelers around the world.
But the condition may no longer need to put your travel plans on pause.
The Food and Drug Administration (FDA) recently approved a new drug that could quickly eradicate the symptoms when you’re on the road.
Aemcolo, an antibacterial drug, will work to eradicate the symptoms of Traveler’s Diarrhea caused by E. coli. It is expected to be available to Americans in February 2019. The pill should be taken orally over the course of three or four days to alleviate symptoms.
According to the company that developed Aemcolo, it is the first antibiotic the FDA has approved for the treatment of Traveler’s Diarrhea in over a decade.
The FDA defines Traveler’s Diarrhea as “having three or more unformed stools in 24 hours” while you’re traveling. It is caused by “a variety of pathogens, but most commonly bacteria found in food and water.” It can happen anywhere but the highest risk destinations for American travelers are throughout Asia, the Middle East, Africa, Mexico, and Central and South America.
The treatment wasn’t effective in cases where diarrhea was complicated by a fever or bloody stool. Aemcolo also won’t work for cases of Traveler’s Diarrhea caused by “pathogens other than noninvasive strains of E. coli,” according to the FDA.
Aemcolo’s most common side effects were headache and constipation.
The pill should be available at pharmacies to purchase before (or even during) your trip.